Syncom Formulations (India) Limited announced that tenure completion of Shri Vinod Kumar Kabra, Shri Krishna Das Neema and Shri Praveen Jindal Independent Director(s) of the Company appointed w.e.f., 1 April, 2014 for a tenure of five (5) year and further were re-appointed w.e.f. 1 April, 2019 for further tenure of five (5) year in the category of Non-Executive Independent Directors of the company w.e.f. close of working hour of 31 March, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.74 INR | +0.37% | +3.08% | -8.64% |
03-29 | Syncom Formulations Limited Announces Board Changes | CI |
02-14 | Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-8.64% | 147M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- SYNCOMF Stock
- News Syncom Formulations (India) Limited
- Syncom Formulations Limited Announces Board Changes